Carmen Kivisild's Linkedin Analytics

I am the CEO and cofounder of Elnora AI, a company transforming drug discovery by creating a unique 'negative' dataset to improve drug target identification. I hold a PhD in neuroscience from University College London and have over 12 years of experience researching novel drug targets, including antiviral research during my postdoctoral work at King's College London. My passion lies in turning laboratory discoveries into life-saving medicines. At Elnora AI, we are building an AI-powered platform to revolutionize drug target identification and validation. By collecting detailed experimental data—both successes and failures—from researchers around the world, we are addressing the 90% failure rate in drug discovery. Our first product, the Biomedical Protocol Optimizer (BiPO), helps create reproducible, unbiased datasets, promotes Open and FAIR science, and aims to eliminate animal testing in research. This tool accelerates drug discovery by years and saves hundreds of millions, while building an ML-readable dataset for truly novel and successful drug targets. Guided by principles of profit, planet, and people, I am committed to transforming cutting-edge research into real-world solutions that save lives.